Creatine decreases convulsions and neurochemical alterations induced by glutaric acid in rats

Brain Research

Volumn 1185, Issue 1, 2007, Pages 336-345

  Magni, Danieli Valnes ^a   Oliveira, Mauro Schneider ^a,c   Furian, Ana Flávia ^a,c   Fiorenza, Natália Gindri ^a   Fighera, Michele Rechia ^a,b   Ferreira, Juliano ^d   Mello, Carlos Fernando ^a   Royes, Luiz Fernando Freire ^a,b,d  

^a Centro de Ciencias da Sau   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Departamento de Química   (Brazil)

Author keywords

Convulsion; Creatine; Glutamate; Glutaric acid; Oxidative damage; Striatum

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CREATINE; GLUTAMIC ACID; GLUTARIC ACID;

ACIDEMIA; AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN PROTECTION; BRAIN SYNAPTOSOME; CARBONYLATION; CONTROLLED STUDY; CONVULSION; DRUG DOSE COMPARISON; ENZYME INHIBITION; EPILEPTOGENESIS; GLUTARIC ACIDEMIA TYPE 1; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CREATINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; GLUTARATES; MALE; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; SEIZURES; SODIUM-POTASSIUM-EXCHANGING ATPASE; SYNAPTOSOMES;

RATTUS;

EID: 36448953931     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.09.023     Document Type: Article

References (68)

1. Amato A., Connolly C.N., Moss S.J., and Smart T.G. Modulation of neuronal and recombinant GABAA receptors by redox reagents. J. Physiol. 517 Pt1 (1999) 35-50
2. Andres R.H., Ducray A.D., Perez-Bouza A., Schlattner U., Huber A.W., Krebs S.H., Seiler R.W., Wallimann T., and Widmer H.R. Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system. Cell Transplant 14 (2005) 537-550
3. Baric I., Zschocke J., Christensen E., Duran M., Goodman S.I., Leonard J.V., Muller E., Morton D.H., Superti-Furga A., and Hoffmann G.F. Diagnosis and management of glutaric aciduria type I. J. Inherit. Metab. Dis. 21 (1998) 326-340
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Cassarino D.S., Parks J.K., Parker Jr. W.D., and Bennett Jr. J.P. The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Acta 1453 (1999) 49-62
6. Das A.M., Lucke T., and Ullrich K. Glutaric aciduria I: creatine supplementation restores creatinephosphate levels in mixed cortex cells from rat incubated with 3-hydroxyglutarate. Mol. Genet. Metab. 78 (2003) 108-111
7. de Mello C.F., Begnini J., Jimenez-Bernal R.E., Rubin M.A., de Bastiani J., da Costa Jr. E., and Wajner M. Intrastriatal methylmalonic acid administration induces rotational behavior and convulsions through glutamatergic mechanisms. Brain Res. 721 (1996) 120-125
8. de Oliveira Marques F., Hagen M.E., Pederzolli C.D., Sgaravatti A.M., Durigon K., Testa C.G., Wannmacher C.M., de Souza Wyse A.T., Wajner M., and Dutra-Filho C.S. Glutaric acid induces oxidative stress in brain of young rats. Brain Res. 964 (2003) 153-158
9. Demarque M., Villeneuve N., Manent J.B., Becq H., Represa A., Ben-Ari Y., and Aniksztejn L. Glutamate transporters prevent the generation of seizures in the developing rat neocortex. J. Neurosci. 24 (2004) 3289-3294
10. Dolder M., Walzel B., Speer O., Schlattner U., and Wallimann T. Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J. Biol. Chem. 278 (2003) 17760-17766
11. Dringenberg H.C., Vanderwolf C.H., and Noseworthy P.A. Superior colliculus stimulation enhances neocortical serotonin release and electrocorticographic activation in the urethane-anesthetized rat. Brain Res. 964 (2003) 31-41
12. Dunkley P.R., Jarvie P.E., Heath J.W., Kidd G.J., and Rostas J.A. A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res. 372 (1986) 115-129
13. Ferreira L.G., De Toledo Bergamaschi C., Lazaretti-Castro M., and Heilberg I.P. Effects of creatine supplementation on body composition and renal function in rats. Med. Sci. Sports Exerc. 37 (2005) 1525-1529
14. Fighera M.R., Bonini J.S., de Oliveira T.G., Frussa-Filho R., Rocha J.B., Dutra-Filho C.S., Rubin M.A., and Mello C.F. GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid. Int. J. Biochem. Cell Biol. 35 (2003) 465-473
15. Fighera M.R., Royes L.F., Furian A.F., Oliveira M.S., Fiorenza N.G., Frussa-Filho R., Petry J.C., Coelho R.C., and Mello C.F. GM1 ganglioside prevents seizures, Na+,K+-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole. Neurobiol. Dis. 22 (2006) 611-623
16. Fiske C.H., and Subbarow Y. The colorimetric determination of phosphorus. J. Biol. Chem. 66 (1925) 375-400
17. Floret D., Divry P., Dingeon N., and Monnet P. Glutaric aciduria. 1 new case. Arch. Fr. Pediatr. 36 (1979) 462-470
18. Flott-Rahmel B., Falter C., Schluff P., Fingerhut R., Christensen E., Jakobs C., Musshoff U., Fautek J.D., Deufel T., Ludolph A., and Ullrich K. Nerve cell lesions caused by 3-hydroxyglutaric acid: a possible mechanism for neurodegeneration in glutaric acidaemia I. J. Inherit. Metab. Dis. 20 (1997) 387-390
19. Freudenberg F., Lukacs Z., and Ullrich K. 3-Hydroxyglutaric acid fails to affect the viability of primary neuronal rat cells. Neurobiol. Dis. 16 (2004) 581-584
20. Frizzo M.E., Schwarzbold C., Porciuncula L.O., Dalcin K.B., Rosa R.B., Ribeiro C.A., Souza D.O., and Wajner M. 3-hydroxyglutaric acid enhances glutamate uptake into astrocytes from cerebral cortex of young rats. Neurochem. Int. 44 (2004) 345-353
21. Fujimoto S., Shibata I., Sugiyama N., Ohba S., Togari H., and Wada Y. Unique electroencephalographic change of acute encephalopathy in glutaric aciduria type 1. Tohoku J. Exp. Med. 191 (2000) 31-38
22. Funk C.B., Prasad A.N., Frosk P., Sauer S., Kolker S., Greenberg C.R., and Del Bigio M.R. Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 128 (2005) 711-722
23. Goodman S.I., Norenberg M.D., Shikes R.H., Breslich D.J., and Moe P.G. Glutaric aciduria: biochemical and morphologic considerations. J. Pediatr. 90 (1977) 746-750
24. Gregersen N., and Brandt N.J. Ketotic episodes in glutaryl-CoA dehydrogenase deficiency (glutaric aciduria). Pediatr. Res. 13 (1979) 977-981
25. Hoffmann G.F., and Zschocke J. Glutaric aciduria type I: from clinical, biochemical and molecular diversity to successful therapy. J. Inherit. Metab. Dis. 22 (1999) 381-391
26. Holtzman D., Togliatti A., Khait I., and Jensen F. Creatine increases survival and suppresses seizures in the hypoxic immature rat. Pediatr. Res. 44 (1998) 410-414
27. Karpiak S.E., Mahadik S.P., Graf L., and Rapport M.M. An immunological model of epilepsy: seizures induced by antibodies to GM1 ganglioside. Epilepsia 22 (1981) 189-196
28. Kelly A., and Stanley C.A. Disorders of glutamate metabolism. Ment. Retard. Dev. Disabil. Res. Rev. 7 (2001) 287-295
29. Klivenyi P., Ferrante R.J., Matthews R.T., Bogdanov M.B., Klein A.M., Andreassen O.A., Mueller G., Wermer M., Kaddurah-Daouk R., and Beal M.F. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5 (1999) 347-350
30. Klivenyi P., Gardian G., Calingasan N.Y., Yang L., and Beal M.F. Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J. Mol. Neurosci. 21 (2003) 191-198
31. Kolker S., Ahlemeyer B., Krieglstein J., and Hoffmann G.F. 3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. J. Inherit. Metab. Dis. 22 (1999) 259-262
32. Kolker S., Ahlemeyer B., Krieglstein J., and Hoffmann G.F. Cerebral organic acid disorders induce neuronal damage via excitotoxic organic acids in vitro. Amino Acids 18 (2000) 31-40
33. Kolker S., Ahlemeyer B., Krieglstein J., and Hoffmann G.F. Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase deficiency. Pediatr. Res. 47 (2000) 495-503
34. Kolker S., Ahlemeyer B., Krieglstein J., and Hoffmann G.F. Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr. Res. 50 (2001) 76-82
35. Kolker S., Kohr G., Ahlemeyer B., Okun J.G., Pawlak V., Horster F., Mayatepek E., Krieglstein J., and Hoffmann G.F. Ca(2+) and Na(+) dependence of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr. Res. 52 (2002) 199-206
36. Kolker S., Okun J.G., Ahlemeyer B., Wyse A.T., Horster F., Wajner M., Kohlmuller D., Mayatepek E., Krieglstein J., and Hoffmann G.F. Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons. J. Neurosci. Res. 68 (2002) 424-431
37. Ipsiroglu O.S., Stromberger C., Ilas J., Höger H., Mühl A., and Stöcler-Ipsiroglu S. Changes of tissue creatine concentrations upon oral supplementation of creatine-monohydrate in various animals species. Life Sci. 69 (2001) 1805-1815
38. Latini A., Borba Rosa R., Scussiato K., Llesuy S., Bello-Klein A., and Wajner M. 3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses in cerebral cortex of young rats. Brain Res. 956 (2002) 367-373
39. Latini A., Scussiato K., Leipnitz G., Dutra-Filho C.S., and Wajner M. Promotion of oxidative stress by 3-hydroxyglutaric acid in rat striatum. J. Inherit. Metab. Dis. 28 (2005) 57-67
40. Lawler J.M., Barnes W.S., Wu G., Song W., and Demaree S. Direct antioxidant properties of creatine. Biochem. Biophys. Res. Commun. 290 (2002) 47-52
41. Leist M., and Nicotera P. Calcium and neuronal death. Rev. Physiol., Biochem. Pharmacol. 132 (1998) 79-125
42. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., and Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186 (1990) 464-478
43. Liesert M., Zschocke J., Hoffmann G.F., Muhlhauser N., and Buckel W. Biochemistry of glutaric aciduria type I: activities of in vitro expressed wild-type and mutant cDNA encoding human glutaryl-CoA dehydrogenase. J. Inherit. Metab. Dis. 22 (1999) 256-258
44. Lima T.T., Begnini J., de Bastiani J., Fialho D.B., Jurach A., Ribeiro M.C., Wajner M., and de Mello C.F. Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid. Brain Res. 802 (1998) 55-60
45. Malcon C., Kaddurah-Daouk R., and Beal M.F. Neuroprotective effects of creatine administration against NMDA and malonate toxicity. Brain Res. 860 (2000) 195-198
46. Michaels R.L., and Rothman S.M. Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. J. Neurosci. 10 (1990) 283-292
47. Migues P.V., Leal R.B., Mantovani M., Nicolau M., and Gabilan N.H. Synaptosomal glutamate release induced by the fraction Bc2 from the venom of the sea anemone Bunodosoma caissarum. NeuroReport 10 (1999) 67-70
48. Milh M., Becq H., Villeneuve N., Ben-Ari Y., and Aniksztejn L. Inhibition of glutamate transporters results in a "suppression-burst" pattern and partial seizures in the newborn rat. Epilepsia 48 (2007) 169-174
49. Morton D.H., Bennett M.J., Seargeant L.E., Nichter C.A., and Kelley R.I. Glutaric aciduria type I: a common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster County, Pennsylvania. Am. J. Med. Genet. 41 (1991) 89-95
50. Nagy A.K., Shuster T.A., and Delgado-Escueta A.V. Ecto-ATPase of mammalian synaptosomes: identification and enzymic characterization. J. Neurochem. 47 (1986) 976-986
51. Nanitsos E.K., Acosta G.B., Saihara Y., Stanton D., Liao L.P., Shin J.W., Rae C., and Balcar V.J. Effects of glutamate transport substrates and glutamate receptor ligands on the activity of Na-/K(+)-ATPase in brain tissue in vitro. Clin. Exp. Pharmacol. Physiol. 31 (2004) 762-769
52. Nathanson J.A., Scavone C., Scanlon C., and McKee M. The cellular Na+ pump as a site of action for carbon monoxide and glutamate: a mechanism for long-term modulation of cellular activity. Neuron 14 (1995) 781-794
53. O'Gorman E., Beutner G., Dolder M., Koretsky A.P., Brdiczka D., and Wallimann T. The role of creatine kinase in inhibition of mitochondrial permeability transition. FEBS Lett. 414 (1997) 253-257
54. Petrushanko I., Bogdanov N., Bulygina E., Grenacher B., Leinsoo T., Boldyrev A., Gassmann M., and Bogdanova A. Na-K-ATPase in rat cerebellar granule cells is redox sensitive. Am. J. Physiol., Regul. Integr. Comp. Physiol. 290 (2006) R916-R925
55. Porciuncula L.O., Dal-Pizzol Jr. A., Coitinho A.S., Emanuelli T., Souza D.O., and Wajner M. Inhibition of synaptosomal [3H]glutamate uptake and [3H]glutamate binding to plasma membranes from brain of young rats by glutaric acid in vitro. J. Neurol. Sci. 173 (2000) 93-96
56. Porciuncula L.O., Emanuelli T., Tavares R.G., Schwarzbold C., Frizzo M.E., Souza D.O., and Wajner M. Glutaric acid stimulates glutamate binding and astrocytic uptake and inhibits vesicular glutamate uptake in forebrain from young rats. Neurochem. Int. 45 (2004) 1075-1086
57. Rosa R.B., Schwarzbold C., Dalcin K.B., Ghisleni G.C., Ribeiro C.A., Moretto M.B., Frizzo M.E., Hoffmann G.F., Souza D.O., and Wajner M. Evidence that 3-hydroxyglutaric acid interacts with NMDA receptors in synaptic plasma membranes from cerebral cortex of young rats. Neurochem. Int. 45 (2004) 1087-1094
58. Royes L.F., Fighera M.R., Furian A.F., Oliveira M.S., da Silva L.G., Malfatti C.R., Schneider P.H., Braga A.L., Wajner M., and Mello C.F. Creatine protects against the convulsive behavior and lactate production elicited by the intrastriatal injection of methylmalonate. Neuroscience 118 (2003) 1079-1090
59. Royes L.F., Fighera M.R., Furian A.F., Oliveira M.S., Myskiw Jde C., Fiorenza N.G., Petry J.C., Coelho R.C., and Mello C.F. Effectiveness of creatine monohydrate on seizures and oxidative damage induced by methylmalonate. Pharmacol. Biochem. Behav. 83 (2006) 136-144
60. Schneider Oliveira M., Flavia Furian A., Freire Royes L.F., Rechia Fighera M., de Carvalho Myskiw J., Gindri Fiorenza N., and Mello C.F. Ascorbate modulates pentylenetetrazol-induced convulsions biphasically. Neuroscience 128 (2004) 721-728
61. Sepkuty J.P., Cohen A.S., Eccles C., Rafiq A., Behar K., Ganel R., Coulter D.A., and Rothstein J.D. A neuronal glutamate transporter contributes to neurotransmitter GABA synthesis and epilepsy. J. Neurosci. 22 (2002) 6372-6379
62. Sestili P., Martinelli C., Bravi G., Piccoli G., Curci R., Battistelli M., Falcieri E., Agostini D., Gioacchini A.M., and Stocchi V. Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. Free Radic. Biol. Med. 40 (2006) 837-849
63. Ullrich K., Flott-Rahmel B., Schluff P., Musshoff U., Das A., Lucke T., Steinfeld R., Christensen E., Jakobs C., Ludolph A., Neu A., and Roper R. Glutaric aciduria type I: pathomechanisms of neurodegeneration. J. Inherit. Metab. Dis. 22 (1999) 392-403
64. Volterra A., Trotti D., Tromba C., Floridi S., and Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14 (1994) 2924-2932
65. Wajner M., Kolker S., Souza D.O., Hoffmann G.F., and de Mello C.F. Modulation of glutamatergic and GABAergic neurotransmission in glutaryl-CoA dehydrogenase deficiency. J. Inherit. Metab. Dis. 27 (2004) 825-828
66. Wick M., Fujimori H., Michaelis T., and Frahm J. Brain water diffusion in normal and creatine-supplemented rats during transient global ischemia. Magn. Reson. Med. 42 (1999) 798-802
67. Wyse A.T., Streck E.L., Barros S.V., Brusque A.M., Zugno A.I., and Wajner M. Methylmalonate administration decreases Na+,K+-ATPase activity in cerebral cortex of rats. NeuroReport 11 (2000) 2331-2334
68. Wyss M., and Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 80 (2000) 1107-1213